When.com Web Search

  1. Ads

    related to: zantac vs gaviscon dosage reviews and complaints and ratings

Search results

  1. Results From The WOW.Com Content Network
  2. GSK settles two California lawsuits related to heartburn drug ...

    www.aol.com/news/gsk-settles-two-california...

    The drugmaker has settled a series of lawsuits related to Zantac over the past 12 months, including several in California. California is generally seen as a more challenging legal environment for ...

  3. Delaware judge lets more than 70,000 Zantac lawsuits go forward

    www.aol.com/news/delaware-judge-lets-more-70...

    By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that ...

  4. Fate of most remaining Zantac lawsuits weighed by ... - AOL

    www.aol.com/news/fate-most-remaining-zantac...

    Medinilla is presiding over the majority of the nearly 80,000 cases still pending in the United States over Zantac, which was once the world's top-selling drug.

  5. H2 receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/H2_receptor_antagonist

    Cimetidine was the prototypical histamine H 2 receptor antagonist from which later drugs were developed. Cimetidine was the culmination of a project at Smith, Kline & French (SK&F; now GlaxoSmithKline) by James W. Black, C. Robin Ganellin, and others to develop a histamine receptor antagonist that would suppress stomach acid secretion.

  6. Rabeprazole - Wikipedia

    en.wikipedia.org/wiki/Rabeprazole

    Rabeprazole, sold under the brand name Aciphex, among others, is a medication that decreases stomach acid. [6] It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and excess stomach acid production such as in Zollinger–Ellison syndrome. [6]

  7. Zantac settlements - Wikipedia

    en.wikipedia.org/wiki/Zantac_settlements

    The Los Angeles Times headlined "Public Faces Overdose of Similar Drug Names." [14] The market for Zantac [15] and its competitors was described in 2005 as 13.5 billion US dollars. [16] The product's problem was described by The New York Times as being "that a potential cancer-causing contaminant can build up in the drug when stored for long ...